Cti Biopharma reported $108.09M in Loan Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Applied Genetic Technologies AGTC:US USD 6.81M 2.31M
Baxter International BAX:US USD 16.15B 125M
Bristol Myers Squibb BMY:US USD 36.97B 141M
Cti Biopharma CTIC:US USD 108.09M 715K
Cytori Therapeutics CYTX:US USD 4.11M 311K
Eli Lilly And LLY:US USD 14.14B 548.2M
Northwest Biotherapeutics NWBO:US USD 5.94M 10.51M
Novartis NOVN:VX USD 21.24B 2.55B
Novartis NVS:US USD 21.24B 2.55B
Teva Pharmaceutical Industries TEVA:US USD 18.5B 1.87B